Drawing for CSL MOTIVE

USPTO serial 87722137

CSL MOTIVE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SOUDERS, MICHAEL J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CSL MOTIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL, RUSSELL, LLP1055 THOMAS JEFFERSON ST. NW, SUITE 400WASHINGTON, DC 20007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Printed publications, namely, brochures, booklets, and teaching materials in the field of clinical trials for pharmaceutical preparations; Printed publications, namely, brochures, booklets, and teaching materials in the field of biotherapies, blood conditions, and rare diseases via the InternetACTIVE—
041Publication of newsletters, magazines, periodicals, journals and case studies and on-line newsletters, magazines periodicals, journals and case studies containing the results of clinical trials for pharmaceutical preparations; Dissemination of printed educational material in the field of healthcareACTIVE—
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical research and scientific research information in the fields of biotherapies, blood conditions, and rare diseases via the Internet; Providing medical and scientific research information in the fields of pharmaceuticals; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 30, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 30, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2021EX5GSOU EXTENSION 5 GRANTED—
Jan 19, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 6, 2021EXT5SOU EXTENSION 5 FILED—
Jan 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2020EX4GSOU EXTENSION 4 GRANTED—
Jun 24, 2020EXT4SOU EXTENSION 4 FILED—
Jun 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2020EX3GSOU EXTENSION 3 GRANTED—
Jan 6, 2020EXT3SOU EXTENSION 3 FILED—
Jan 6, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 22, 2019EX2GSOU EXTENSION 2 GRANTED—
Jul 22, 2019EXT2SOU EXTENSION 2 FILED—
Jul 22, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 10, 2019EX1GSOU EXTENSION 1 GRANTED—
Jan 10, 2019EXT1SOU EXTENSION 1 FILED—
Jan 10, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2018ALIEASSIGNED TO LIE—
Apr 4, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 16, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 16, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Feb 16, 2018CNSLSUSPENSION LETTER WRITTEN—
Feb 16, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 16, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 16, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 16, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 13, 2018DOCKASSIGNED TO EXAMINER—
Dec 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance